These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6027165)

  • 21. The neurogenically maintained component in hypertension.
    Smirk FH
    Circ Res; 1970 Oct; 27():Suppl 2:55-63. PubMed ID: 5506149
    [No Abstract]   [Full Text] [Related]  

  • 22. Peripheral inhibition of reflexogenic vasodilation induced by veratridine.
    Wellens D
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):247-50. PubMed ID: 5650330
    [No Abstract]   [Full Text] [Related]  

  • 23. Antihypertensive properties of cryptenamine used with reserpine and methyclothiazide.
    Kennedy CC; Spiekerman RE; Elveback L
    J Pharm Sci; 1971 Aug; 60(8):1139-41. PubMed ID: 4942478
    [No Abstract]   [Full Text] [Related]  

  • 24. Guillain-Barré syndrome with hypertension.
    Uyeda CI
    Paediatr Univ Tokyo; 1970 Dec; 18():138-42. PubMed ID: 5514637
    [No Abstract]   [Full Text] [Related]  

  • 25. The metabolic effect of noradrenaline on the isolated canine heart after blockade of the chronotropic action by veratramine.
    Simaan J; Fawaz G
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):199-209. PubMed ID: 4267318
    [No Abstract]   [Full Text] [Related]  

  • 26. [Parallels in the pharmacodynamics of the Germerin alkaloids of veratrum and of the andromedotoxin].
    Petkov W; Tzonev I
    Arztl Forsch; 1966 Jan; 20(1):40-6. PubMed ID: 6013329
    [No Abstract]   [Full Text] [Related]  

  • 27. The mechanism responsible for hypertension in a patient with Guillain-Barré syndrome.
    Minami N; Imai Y; Miura Y; Abe K
    Clin Exp Hypertens; 1995 May; 17(4):607-17. PubMed ID: 7795576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacological action of 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrolinone hydrochloride (doxapram). 1. The action on the central nervous system].
    Kuga T; Naito J
    Nihon Yakurigaku Zasshi; 1973 Sep; 69(5):701-10. PubMed ID: 4148712
    [No Abstract]   [Full Text] [Related]  

  • 29. The sympatho-adrenergic response in hyperthermia.
    Groza P; Cârmaciu R; Boerescu J; Bobic D; Vrâncianu R
    Physiologie; 1976; 13(2):91-9. PubMed ID: 821072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adrenosympathetic activity during sodium depletion in patients with essential hypertension].
    Agabiti-Rosei E; Alicandri C; Bentivoglio M; Corea L; Miele N; Muiesan G
    Boll Soc Ital Cardiol; 1977; 22(8):1413-20. PubMed ID: 618275
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biochemical measurement of the function of the adrenal medulla and sympathetic system in the clinic].
    Jéquier E
    Schweiz Med Wochenschr; 1970 Mar; 100(12):532-6. PubMed ID: 4906883
    [No Abstract]   [Full Text] [Related]  

  • 32. [On a case of Guillain - Barre's polyradiculoneuritis with arterial hypertension (author's transl)].
    Marconi GP; Arretoli G
    Riv Patol Nerv Ment; 1975; 96(4):239-51. PubMed ID: 1232668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous responses to prostaglandin F2 alpha.
    Mark AL; Schmid PG; Eckstein JW; Wendling MG
    Am J Physiol; 1971 Jan; 220(1):222-6. PubMed ID: 4992254
    [No Abstract]   [Full Text] [Related]  

  • 34. [The orthosympathetic system and experimental gastric ulcers].
    Djahanguiri B; Sadeghi D; Hemmati S
    Arch Int Pharmacodyn Ther; 1968 May; 173(1):154-61. PubMed ID: 5657815
    [No Abstract]   [Full Text] [Related]  

  • 35. Electrocardiographic abnormalities and autonomic dysfunction in Guillain-Barré syndrome.
    Hagman A; Malmberg K
    Br Med J (Clin Res Ed); 1982 Aug 28-Sep 4; 285(6342):653. PubMed ID: 6819055
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sympathetic-adrenal medulla system, with special reference to the application of its tests and associated disorders].
    Kawa A; Ogawa T
    Rinsho Byori; 1967 Dec; 15(12):822-7. PubMed ID: 4876821
    [No Abstract]   [Full Text] [Related]  

  • 37. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
    Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
    J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of the sympathetic nervous system in supporting cardiac function in essential arterial hypertension.
    Guazzi M; Magrini F; Fiorentini C; Polese A
    Br Heart J; 1973 Jan; 35(1):55-64. PubMed ID: 4685907
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of nitroprusside-induced hypotension on sympathetic nerve activity, tyrosine hydroxylase activity and [3H]norepinephrine uptake in rabbit vascular tissues.
    Takimoto GS; Weiner N
    J Pharmacol Exp Ther; 1981 Nov; 219(2):420-7. PubMed ID: 6116800
    [No Abstract]   [Full Text] [Related]  

  • 40. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events.
    Cryer PE; Haymond MW; Santiago JV; Shah SD
    N Engl J Med; 1976 Sep; 295(11):573-7. PubMed ID: 950972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.